$2500 | Single User
$5000 | Site License
$7500 | Global License

Chemotherapy Induced Pain Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

Published by Global Data: 31 Dec 2018 | 230682 | In Stock

Introduction

Chemotherapy Induced Pain Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, “Chemotherapy Induced Pain Global Clinical Trials Review, H2, 2018" provides an overview of Chemotherapy Induced Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Chemotherapy Induced Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Chemotherapy Induced Pain Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    GlobalData Clinical Trials Report Coverage 6

    Clinical Trials by Region 7

    Clinical Trials and Average Enrollment by Country 8

    Top Countries Contributing to Clinical Trials in Asia-Pacific 11

    Top Five Countries Contributing to Clinical Trials in Europe 12

    Top Countries Contributing to Clinical Trials in North America 13

    Top Countries Contributing to Clinical Trials in Middle East and Africa 14

    Top Countries Contributing to Clinical Trials in Central and South America 15

    Clinical Trials by G7 Countries: Proportion of Chemotherapy Induced Pain to Central Nervous System Clinical Trials 16

    Clinical Trials by Phase in G7 Countries 17

    Clinical Trials in G7 Countries by Trial Status 18

    Clinical Trials by E7 Countries: Proportion of Chemotherapy Induced Pain to Central Nervous System Clinical Trials 19

    Clinical Trials by Phase in E7 Countries 21

    Clinical Trials in E7 Countries by Trial Status 22

    Clinical Trials by Phase 23

    In Progress Trials by Phase 24

    Clinical Trials by Trial Status 25

    Clinical Trials by End Point Status 26

    Subjects Recruited Over a Period of Time 27

    Clinical Trials by Sponsor Type 28

    Prominent Sponsors 29

    Top Companies Participating in Chemotherapy Induced Pain Therapeutics Clinical Trials 30

    Prominent Drugs 31

    Clinical Trial Profile Snapshots 32

    Appendix 42

    Abbreviations 42

    Definitions 42

    Research Methodology 43

    Secondary Research 43

    About GlobalData 44

    Contact Us 44

    Source 44

List Of Tables
in Chemotherapy Induced Pain Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

List of Tables

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Region, 2018* 7

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Chemotherapy Induced Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11

Chemotherapy Induced Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12

Chemotherapy Induced Pain Therapeutics Clinical Trials, North America, Top Countries, 2018* 13

Chemotherapy Induced Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14

Chemotherapy Induced Pain Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15

Proportion of Chemotherapy Induced Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 16

Chemotherapy Induced Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Chemotherapy Induced Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18

Proportion of Chemotherapy Induced Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 20

Chemotherapy Induced Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21

Chemotherapy Induced Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Phase, 2018* 23

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 24

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27

Chemotherapy Induced Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 28

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 31

List Of Figures, Charts and Diagrams
in Chemotherapy Induced Pain Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

List of Figures

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Chemotherapy Induced Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 11

Chemotherapy Induced Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12

Chemotherapy Induced Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13

Proportion of Chemotherapy Induced Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 16

Chemotherapy Induced Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Chemotherapy Induced Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18

Proportion of Chemotherapy Induced Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 19

Chemotherapy Induced Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21

Chemotherapy Induced Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Phase (%), 2018* 23

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 24

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27

Chemotherapy Induced Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 28

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 31

GlobalData Methodology 43

Additional Details

Publisher

Global Data

Publisher Information

Reference

230682 | GDHC5546CTIDB

Number of Pages

44

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Latin America Infusion Pump Market by Product (Volumetric, Syringe, Feeding, Insulin, PCA Pump), Application (Chemotherapy, Gastroenterology, Diabetes, Pain Management), Setting (Hospital, Ambulatory Centers), Accessories - Forecast to 2021
The Latin American infusion pumps and accessories market is estimated to reach USD 671.9 million by ...
20 Sep 2016 by MarketsandMarkets USD $5,650 More Info
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2016
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial ...
29 Jun 2016 by Global Data USD $2,500 More Info
Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2016
Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical...
15 Jun 2016 by Global Data USD $2,500 More Info
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016SummaryGlobalData'...
15 Jun 2016 by Global Data USD $2,500 More Info
Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2016
Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical tria...
15 Jun 2016 by Global Data USD $2,500 More Info
Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H1, 2016
Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H1, 2016SummaryGlobalData's ...
30 Apr 2016 by Global Data USD $2,500 More Info
Infusion Pump Market - by Product (Volumetric, Syringe, Feeding, Insulin, PCA Pump), by Application (Chemotherapy, Gastroenterology, Diabetes, Pain Management), by End User (Hospital, Home Care, Ambulatory Surgery Centers) - Global Forecast to 2020
The global infusion pumps and accessories market is expected to grow at a CAGR of 5.8% during the fo...
11 Jan 2016 by MarketsandMarkets USD $4,650 More Info
Chemotherapy Induced Anemia Global Clinical Trials Review, H2, 2015
Chemotherapy Induced Anemia Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical tria...
25 Nov 2015 by Global Data USD $2,500 More Info
Physician Views: Can Astellas, Medivation's Xtandi meet expectations in pre-chemotherapy prostate cancer?
Scope Having secured approval for the treatment of pre-chemotherapy prostate cancer patients earlier...
25 Sep 2014 by FirstWord Pharma USD $695 More Info
Physician Views: What is reaction among urologists, oncologists to the Xtandi PREVAIL data – can it displace Zytiga in the pre-chemotherapy prostate cancer setting?
ScopeThe prostate cancer market looks poised to enter its next stage of evolution in 2014, with Medi...
01 Oct 2013 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

Chemotherapy Induced Pain Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data